KCT0005271尚未招募未知
Sirolimus with reduced calcineurin inhibitor regimen in ABO incompatible kidney transplantation
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 60(Year)（—）
- 性别
- All
入选标准
- •Recipients who underwent ABOi KT meeting all of the following criteria will be enrolled in the study
- •1) aged over than 18 years and less than 60 years
- •2) patients willing and able to give informed consent
排除标准
- •Patients who have not received other organ transplantation
- •Patients with PRA (panel reactive antibody) test value > 50%
- •Patients with DSA(Donor specific antibody) MFI test value >3000
- •Patients with positive Lymphocyte cross-match
- •History of malignancy of any organ system within 5years
- •Patients with active infection
- •Patients who received medication related with other clinical trials
- •Patients who had follwing conditions
- •1) Severe uncontrolled hypercholesterolemia or hypertriglyceridemia
- •2) Abnormal liver function (AST, ALT, ALKP, total bilirubin) : more than three times higher than the standard value
- •3) White blood cell count =3,000 /mm3 (or absulute neutrophile count <1,000 mm3) or platelet count =75,000 /mm3
研究者
相似试验
已完成
不适用
Substitution of calcineurin inhibitors with sirolimus on left ventricular hypertrophy (LVH) of renal transplant recipients (RTR)Chronic allograft nephropathy in renal transplant recipientsleft ventricular hypertrophyInjury, Occupational Diseases, PoisoningFailure and rejection of transplanted organs and tissuesISRCTN54216890San Martino University Hospital (Azienda Ospedaliera Universitaria San Martino) (Italy)42
已完成
4 期
Study Evaluating Sirolimus in the Treatment of Kidney TransplantKidney FailureKidney DiseasesNCT00282217Wyeth is now a wholly owned subsidiary of Pfizer100
进行中（未招募）
1 期
A Phase I/II Study of Sirolimus (Rapamune TM) in Combination with Cyclophosphamide and Dexamethasone in Relapsed Myeloma - SCD1 TrialPlasma Cell MyelomaEUCTR2005-000656-33-GBRoyal Devon and Exeter NHS Foundation Trust18
已完成
2 期
Trial of Sirolimus cream to prevent skin cancers in organ transplant recipients.Keratinocyte cancerCancer - Non melanoma skin cancerSquamous cell carcinomaBasal cell carcinomaACTRN12618001961235niversity of Queensland Diamantina Institute19
进行中（未招募）
1 期
Prospective comparison of sirolimus against corticosteroids in treatment of patients with active thyroid eye diseaseThyroid eye diseaseCTIS2023-510166-27-01Helse Bergen HF70